Harvard Bioscience (HBIO) Cash from Operations Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -28.74% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.99% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -15.62% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 262.94% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 34.32% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 90.02% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -4.50% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -88.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -88.20% |
| Mar 31, 2026 | -122.17% |
| Dec 31, 2025 | -105.57% |
| Sep 30, 2025 | 228.74% |
| Jun 30, 2025 | 425.65% |
| Mar 31, 2025 | 112.83% |
| Dec 31, 2024 | -59.91% |
| Sep 30, 2024 | -119.31% |
| Jun 30, 2024 | -123.82% |
| Mar 31, 2024 | -22.57% |
| Dec 31, 2023 | 60.62% |
| Sep 30, 2023 | 571.96% |
| Jun 30, 2023 | 1,969.47% |
| Mar 31, 2023 | 191.24% |
| Dec 31, 2022 | 2,189.74% |
| Sep 30, 2022 | 198.33% |
| Jun 30, 2022 | -124.74% |
| Mar 31, 2022 | -291.51% |
| Dec 31, 2021 | -95.30% |
| Sep 30, 2021 | -141.33% |